Delivery Order SPE2DB20D3103-SPE2DB25FP8L9
Award Date 8/12/25
Potential Completion Date 9/3/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for GAMUNEX-C 20 gram/200 milliliter vials valued at $11,801.40 with firm fixed pricing. This is a non-set-aside delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is executing this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Gamunex-C 5 gram/50 ml vials valued at $1,518.35, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a potential value of $999,999,999 and...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials valued at $56,646.72. This is a firm fixed-price, non-set-aside contract with a completion date of August 25, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. GAMUNEX-C is an immune globulin intravenous (human) treatment used for immunodeficiency and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Gamunex-C 1 gram/10 milliliter vials with a ceiling value of $1,223.80 and a completion date of September 3, 2025. This non-set-aside, firm fixed-price delivery order represents a competitively awarded contract under the company's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials valued at $11,651.54 under a firm fixed-price contract with an ultimate completion date of August 18, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of GAMUNEX-C 10 gram/100 milliliter vials, with a ceiling value of $9,157.05 and an ultimate completion date of August 22, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin used to treat immunodeficiency and autoimmune...
- The Defense Logistics Agency awarded a $41,178.10 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This competitively awarded, firm fixed-price contract is non-set-aside and scheduled for completion by August 21, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an immune globulin intravenous (human) product used in treating immune deficiency disorders and is a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of GAMUNEX-C (40 gram/400 mL vial) with a ceiling value of $2,327.20. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of GAMUNEX-C 10 gram/100 mL vials valued at $1,220.94. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Gamunex-C 10 gram/100 mL vials with a ceiling value of $3,662.82. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Gamunex-C is an intravenous immunoglobulin therapy used to treat immune deficiency disorders and...